Lymphoma Canada is seeking the views of anyone or has, or has had, diffuse large-B cell lymphoma and has been treated with CAR-T cell therapy.
The charity has prepared a survey to learn more about the experiences of this patient population. Responses will help Lymphoma Canada prepare the patient input required for its submission to the pan-Canadian Oncology Drug Review (pCODR). pCODR uses this information to help them make recommendations to Canadian public drug plans regarding funding for new cancer drugs.
You do not need to live in Canada to complete this survey.
The survey, which is open until midnight (PT) on Friday 11 May 11, takes approximately 10 minutes to complete.